605369.SH
Zhejiang Gongdong Medical Technology Co., Ltd.
SSE · Healthcare · Medical - Instruments & Supplies · CN
CNY 17.52
+1.15%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.2B | 1.1B | 1.1B | 975.1M | 1.5B |
| Cost of Revenue | 835.3M | 819.2M | 749.5M | 656.7M | 888.6M |
| Gross Profit | 324.5M | 316.5M | 365.7M | 318.4M | 580.1M |
| Operating Expenses | |||||
| R&D Expense | 46.6M | 45.6M | 53.0M | 47.8M | 72.3M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 91.6M | 92.9M | 89.2M | 83.1M | 99.1M |
| Selling & Marketing Expense | 55.9M | 56.0M | 52.0M | 65.1M | 63.4M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 209.9M | 204.1M | 180.8M | 202.9M | 203.3M |
| Cost and Expenses | 1.0B | 1.0B | 930.2M | 859.6M | 1.1B |
| Operating Income (EBIT) | 74.8M | 65.2M | 191.6M | 119.7M | 371.8M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 72.9M | 62.8M | 188.7M | 119.2M | 370.7M |
| Income Tax Expense | 16.8M | 11.5M | 17.2M | 10.1M | 44.6M |
| Bottom Line | |||||
| Net Income | 56.1M | 51.5M | 171.6M | 109.1M | 326.0M |
| Earnings from Cont. Ops | 56.1M | 51.4M | 171.5M | 109.1M | 326.0M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 56.1M | 51.5M | 171.6M | 109.1M | 326.0M |
| Per Share | |||||
| Basic EPS | CN¥0.26 | CN¥0.23 | CN¥0.78 | CN¥0.69 | CN¥2.91 |
| Diluted EPS | CN¥0.26 | CN¥0.23 | CN¥0.78 | CN¥0.69 | CN¥2.91 |
| Revenue Per Share | CN¥5.44 | CN¥5.07 | CN¥5.07 | CN¥6.17 | CN¥13.11 |
| Shares | |||||
| Basic Shares Outstanding | 213.3M | 223.9M | 220.0M | 158.2M | 112.0M |
| Diluted Shares Outstanding | 213.3M | 223.9M | 220.0M | 158.2M | 112.0M |
| Profitability Metrics | |||||
| EBITDA | — | 168.2M | 287.1M | 205.4M | 412.5M |
| D&A | — | 103.0M | 95.5M | 85.7M | 40.7M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026